Login / Signup

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.

Gordon ChuJaap SeeligEmmy M Trinks-RoerdinkAnouk P van AlemMarco AlingsBart van den BemtLucas Va BoersmaMarc A BrouwerSuzanne C CannegieterHugo Ten CateCharles Jhj KirchhofHarry J G M CrijnsEwoud J van DijkArif ElvanIsabelle C van GelderJoris R de GrootFrank R den HartogJonas Ssg de JongSylvie de JongFrederikus A KlokTimo LenderinkJustin G LuermansJoan G MeederRon PistersPeter PolakMichiel RienstraFrans SmeetsGiovanni Jm TahaparyLuc TheunissenRobert G TielemanSerge A TrinesPepijn van der VoortGeert-Jan GeersingFrans H RuttenMartin Ew HemelsMenno V Huisman
Published in: BMJ open (2020)
Trial NL7467, NTR7706 (https://www.trialregister.nl/trial/7464).
Keyphrases
  • study protocol
  • clinical trial
  • phase iii
  • atrial fibrillation
  • phase ii
  • open label
  • cross sectional
  • combination therapy
  • replacement therapy
  • placebo controlled